Of the 27 liquid KRAS‐positive patients with adenocarcinoma, 25 were diagnosed histologically, seven (28.0%) had mucinous adenocarcinoma and 18 (72.0%) had nonmucinous adenocarcinoma. The gene discussed is KRAS; the disease is colon mucinous adenocarcinoma.